Skip to content
StockMarketAgent
Healthcare / Pharmaceutical RetailersUpdated 2026-05-10 22:07 UTC

IDX/MMIX stock hub

IDX/MMIX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

IDX/MMIXis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.7T
Indonesia Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
IDX/MMIX
In the news

Latest news · IDX/MMIX

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 9.4P50 14.4P75 23.9
Trailing P/E156.5
P25 11.5P50 23.8P75 52.6
ROE3
P25 0.6P50 5.1P75 12.2
ROIC6
P25 1.3P50 6P75 11.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All IDX/MMIX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
194
Groups with data
11
Currency
IDR
Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
Indonesia
Country code
ID
Employees
72
Employees Change
-3%
Employees Change Percent
-4
Enterprise value
IDR 1.9T
Exchange
Indonesia Stock Exchange
Financial currency
IDR
First seen
2026-05-10
Industry
Pharmaceutical Retailers
Last refreshed
2026-05-10
Market cap
IDR 1.7T
Price
IDR 358
Price currency
IDR
Rev Per Employee
2,815,614,229.31x
Sector
Healthcare
Sic
5122
Symbol
idx/MMIX
Website
https://www.multimed.co.id

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
0.32%
EV Earnings
346.05x
EV/EBIT
60.2x
EV/EBITDA
14.21x
EV/FCF
104.97x
EV/Sales
9.37x
FCF yield
1.05%
P/B ratio
9.16x
P/E ratio
156.5x
P/S ratio
8.48x
PE Ratio3 Y
92.84x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

22
MetricValue
EBIT Margin
15.57%
EBITDA Margin
65.33%
FCF margin
8.93%
Gross margin
58.89%
Gross Profit
IDR 119.4B
Gross Profit Growth
-0.66%
Gross Profit Growth Q
-7.36%
Gross Profit Growth3 Y
5.83%
Net Income
IDR 5.5B
Net Income Growth
33.27%
Net Income Growth Q
20.62%
Net Income Growth3 Y
-40.91%
Pretax Margin
4%
Profit Margin
2.71%
Profit Per Employee
IDR 76.3M
ROA
4.74
Roa5y
12.81
ROCE
8.46
ROE
2.97
Roe5y
43.73
ROIC
6.02
Roic5y
46.04

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

8
MetricValue
Cagr1y
401.25%
Cagr3y
25.99%
EPS Growth
166.5
EPS Growth Q
141.2
EPS Growth3 Y
-29.94
Revenue Growth
-3.79x
Revenue Growth Q
2.56x
Revenue Growth3 Y
2.09x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
IDR 0.49
Assets
IDR 425B
Cash
IDR 731.1M
Current Assets
IDR 321.9B
Current Liabilities
IDR 51.8B
Debt
IDR 182.2B
Debt EBITDA
IDR 1.36
Debt Equity
IDR 0.97
Debt FCF
IDR 10.07
Equity
IDR 187.7B
Interest Coverage
31.87
Liabilities
IDR 237.3B
Long Term Assets
IDR 103.2B
Long Term Liabilities
IDR 185.5B
Net Cash
IDR -181.5B
Net Cash By Market Cap
IDR -10.56
Net Debt EBITDA
IDR 1.37
Net Debt Equity
IDR 0.97
Net Debt FCF
IDR 10.03
Tangible Book Value
IDR 186.4B
Tangible Book Value Per Share
IDR 77.65
WACC
12.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
6.21
Inventory Turnover
0.43
Net Working Capital
IDR 269.5B
Quick ratio
1.33
Working Capital
IDR 270B
Working Capital Turnover
IDR 0.74

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
50%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
400.7%
200-day SMA
208.3
3Y total return
100%
50-day SMA
252
50-day SMA vs 200-day SMA
50over200
All Time High
394
All Time High Change
-9.14%
All Time High Date
2026-05-07
All Time Low
25
All Time Low Change
1,332%
All Time Low Date
2024-03-26
ATR
29.56
Beta
1.69
Beta1y
1.28
Beta2y
0.55
Ch YTD
59.82
High
374
High52
394
High52 Date
2026-05-07
High52ch
-9.14%
Low
350
Low52
67.5
Low52 Date
2025-05-09
Low52ch
430.37%
Ma50ch
42.09%
Price vs 200-day SMA
71.87%
RSI
70.1
RSI Monthly
73.55
RSI Weekly
79.97
Sharpe ratio
2.97x
Sortino ratio
5.62
Total Return
50%
Tr YTD
59.82
Tr1m
49.17%
Tr1w
19.33%
Tr3m
65.74%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
IDR 31.6B
Operating Income Growth
18.07
Operating Income Growth Q
2.31
Operating Income Growth3 Y
-2.76
Operating margin
15.57

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
1,200,425,380%
Net Borrowing
-6,597,957,764
Shares Insiders
15%
Shares Out
4,800,425,380
Shares Qo Q
-50%
Shares Yo Y
-50%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
IDR 18.1B
Average Volume
7,365,095x
Bv Per Share
78.2
CAPEX
IDR -351.8M
Ch1m
49.17
Ch1w
19.33
Ch1y
400.7
Ch3m
65.74
Ch3y
100
Ch6m
47.93
Change
-3.24%
Change From Open
-3.24
Close
370
Days Gap
0
Depreciation Amortization
100,872,032,882
Dollar Volume
1,330,184,800
Earnings Date
2026-07-29
EBIT
IDR 31.6B
EBITDA
IDR 132.4B
EPS
IDR 2.29
F Score
6
FCF
IDR 18.1B
FCF EV Yield
0.95x
FCF Per Share
IDR 3.77
Financing CF
-8,597,957,764
Fiscal Year End
December
Founded
2,020
Graham Number
63.44307
Graham Upside
-82.28
Income Tax
IDR 2.6B
Investing CF
-9,651,756,339
Is Primary Listing
1
Last Earnings Date
2025-10-30
Last Report Date
2026-03-31
Last Split Date
2025-10-24
Last Split Type
Forward
Lynch Fair Value
IDR 11.44
Lynch Upside
-96.81
Ma150
232.3
Ma150ch
54.1%
Ma20
300.7
Ma20ch
19.06%
Net CF
202,669,278
Next Earnings Date
2026-07-29
Open
370
P FCF Ratio
94.94
P OCF Ratio
93.13
Position In Range
33.33
Ppne
84,835,646,120
Price Date
2026-05-08
Price EBITDA
IDR 12.98
Ptbv Ratio
9.22
Relative Volume
0.5x
Revenue
202,724,224,510x
Tax By Revenue
1.29x
Tax Rate
32.31%
Tr6m
47.93%
Volume
3,715,600
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does IDX/MMIX pay a dividend?

Capital-return profile for this ticker.

Performance

IDX/MMIX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+400.7%
S&P 500 1Y: n/a
3Y total return
+100.0%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns IDX/MMIX?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+15.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-50.0%
Negative means the company is buying back shares.
Technical

IDX/MMIX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
70.1
Above 70: short-term overbought
Price vs 200-day MA
+71.9%
50/200-day relationship not available
Beta (5Y)
1.69
More volatile than the market
Sharpe ratio
2.97
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About IDX/MMIX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current idx/MMIX stock rating?

idx/MMIX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full idx/MMIX analysis?

The full report lives at /stocks/idx/MMIX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for idx/MMIX?

The latest report frames idx/MMIX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the idx/MMIX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

idx/MMIX stock profile: metrics, valuation and analysis | Agent IA du Marché Boursier